Healthcare Professionals

Committed to helping you enhance your practice and the experience of your patients through connected devices and digitalised data sharing.

Healthcare Professionals
  • Primary Care

    Supporting every aspect of your clinical practice, including physical exam, diagnostic cardiology, vitals monitoring and vision screening

  • Hospital Care

    Advancing products and technologies designed to speed patient recovery and streamline clinical workflows

  • Surgical Care

    Delivering innovations that enable reduced operating times, faster patient recovery and improved outcomes

  • Nutritional Care

    Personalizing nutritional care designed to improve patients’ health in the hospital, the ICU and at home

  • Respiratory Care

    Helping your patients with respiratory therapies designed to simplify delivery and improve mobility

  • Our Products & Services

    Our portfolio of acute, nutritional, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For nearly a century, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our 90-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Leadership

    Our forward-looking leadership team is a driving force in ensuring we meet the needs of all our stakeholders – every day and everywhere.

  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We strive to create lasting value by empowering our patients, protecting our planet and championing our people and communities.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For nearly a century, we’ve been focused on saving and sustaining lives and elevating patient care.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • General Healthcare

    Whether you are receiving care in the hospital, at your doctor’s office or at home, we are here to support every step of your journey.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain your nutritional status.

  • Respiratory Care

    We are committed to helping you with innovative products that deliver effective, proven respiratory therapy in the hospital and at home.

Search Results

Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada

Baxter International Inc. (NYSE:BAX), a leading global medical products company, and Spectral Medical Inc. (TSX:EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced a distribution agreement for TORAYMYXIN™ PMX-20R (PMX), a hemoperfusion filter, and the Endotoxin Activity Assay™ (EAA), an on-market companion diagnostic tool that aids in the risk assessment of ICU patients for progression to severe sepsis.

Baxter to Present at the 9th Annual SVB Leerink Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 9th Annual SVB Leerink Global Healthcare Conference in New York, N.Y. on Wednesday, February 26, 2020. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 9:30 a.m. Eastern Time.

Baxter Announces Preliminary Net Sales for the Fourth-Quarter and Full-Year 2019 and Announces Preliminary Full-Year 2020 Guidance

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced preliminary net sales for the quarter and full year ended December 31, 2019, and preliminary full-year 2020 guidance for select financial metrics.

Baxter to Present at the 38th Annual J.P. Morgan Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.

Baxter to Expand Advanced Surgery Portfolio with Acquisition of Seprafilm Adhesion Barrier

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today entered into a definitive agreement to acquire Seprafilm Adhesion Barrier and related assets from Sanofi. The agreement is the latest example of Baxter's continued focus on acquiring products and technologies that have a strong strategic fit with the company's leading portfolio across the hospital, including in the operating room.

Baxter Receives NYSE Notice Regarding Delayed Form 10-Q Filing

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that the New York Stock Exchange (NYSE) notified the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 with the Securities and Exchange Commission (SEC).

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock. The dividend is payable on Jan. 2, 2020, to shareholders of record as of Dec. 6, 2019. The indicated annual dividend rate is $0.88 per share of common stock. About Baxter

Thumbnail Image for CKD&Me

Baxter and Ayogo Launch CKD&Me Patient Empowering Digital Education Tool at Kidney Week 2019

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, and Ayogo Health Inc., a behavioral science, digital health company, today announced the pilot of CKD&Me in several nephrology practices across the United States. Baxter and Ayogo partnered to build CKD&Me, a unique app for smartphones and tablets that tailors its educational content to chronic kidney disease (CKD) patients’ individual learning needs.

Baxter to Present at the Evercore ISI 2nd Annual HealthCONx Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston on December 4, 2019. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 10:15 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 1, 2020. About Baxter

Baxter to Present at the 28th Annual Credit Suisse Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 28th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz., on November 12, 2019. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 11:30 a.m. Mountain Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through May 10, 2020.